Nearly every private market investment an individual encounters arrives as a private placement — a fund interest, a syndication, a DST, a direct deal. Understanding what that means, and what it does not mean, is the foundation for everything else.
What “exempt” actually changes
A public offering must be registered with the SEC, which requires a registration statement, audited financial statements in prescribed form, and ongoing reporting. The requirements are extensive and expensive, and they exist to ensure investors receive standardised information.
A private placement is exempt from registration, most commonly under Regulation D. The consequences for an investor are specific:
Disclosure is not mandated in the same way. Issuers selling only to accredited investors under Rule 506 have limited prescribed disclosure obligations. Most provide a private placement memorandum anyway — because antifraud rules still apply and because sophisticated buyers demand it — but its scope, quality, and candour vary enormously between issuers.
Nobody reviews the merits. A Form D is a notice filing, not an application. No federal or state agency approves the offering, evaluates the projections, or forms a view on whether the price is fair. The disclaimer to this effect in every offering document exists because investors assume otherwise.
The securities are restricted. They cannot be freely resold. Resale requires registration or an exemption, and the governing documents almost always require the issuer’s consent. See transfer restrictions on private securities.
Antifraud rules still apply. This is the protection that remains, and it is not nothing — material misstatements and omissions are actionable regardless of exemption. But antifraud liability is a remedy after the fact, not a disclosure regime before it.
The three documents
The private placement memorandum describes the offering, the sponsor, the strategy, the terms, and the risks. It is written by the issuer’s counsel with the issuer as client, and it is oriented toward disclosing risks adequately rather than toward helping an investor decide. The risk factors section is genuinely useful and is frequently skimmed.
The governing document — partnership agreement, operating agreement, or trust agreement. This is the one that matters. It contains the actual economics, the waterfall, the manager’s powers, amendment provisions, transfer restrictions, capital call obligations, and what happens in stress.
Where the PPM summary and the governing document differ, the governing document governs. Reading it is the single highest-value piece of work available to an investor, and it is skipped most of the time.
The subscription agreement contains the investor’s representations — accredited status, investment intent, sophistication, and acknowledgment of risk. Signing it is a factual assertion, not a formality.
What investors most often misjudge
That being offered something implies vetting. An offering reaching an investor through an adviser has generally been through some process — a broker-dealer’s reasonable-basis diligence, or an adviser’s own review. That process varies in rigour and is not equivalent to regulatory review. The question “what diligence did your firm do on this?” is fair and the answer is informative.
That the projections are forecasts. They are assumptions arranged into a model. In real estate offerings particularly, the exit assumption drives the projected return more than anything the sponsor will actually do.
That disclosure of a risk neutralises it. A PPM listing concentration, leverage, and illiquidity has discharged a legal obligation. The risks remain exactly as large as before they were disclosed.
That illiquidity is theoretical. It is not. There is generally no exit until the sponsor sells, and secondary sales — where possible at all — happen at a discount to a value the buyer sets.
That the minimum is a guide to sizing. A minimum investment reflects the issuer’s administrative preferences. It says nothing about what proportion of a portfolio the position should represent.
The questions worth asking
- What is the sponsor’s full track record, including deals that went badly? See evaluating a sponsor track record.
- How much of their own capital is in this, on the same terms?
- What are all the fees, including those paid to affiliates?
- What does the waterfall actually say — read in the governing document?
- What is the debt, and when does it mature relative to the projected hold?
- What assumptions drive the projections, and what happens if they are wrong by a modest amount?
- Can the sponsor call more capital, and what happens if I decline?
- Who audits, who administers, and can I confirm them independently?
- What is the exit, and what if it does not happen on schedule?
- What diligence did the recommending firm perform?
A sponsor that answers these readily is behaving normally. One that treats them as adversarial has told the investor something useful at no cost.
Sizing
The most consistent error in private placement investing is not choosing a bad deal. It is sizing a good one wrongly.
An investor who allocates a large proportion of liquid net worth to a single illiquid, concentrated position has taken a risk that no amount of diligence mitigates, because the risk is in the concentration rather than in the asset. Diversification across several placements, across sponsors and vintages, requires capital that many individual investors do not have — which is a reason to consider diversified vehicles rather than a reason to concentrate.
See allocating to alternatives and liquidity budgeting.
The fair summary
Private placements are how private markets are accessed, and many are sound investments run by capable people. The exemption framework is not a loophole; it reflects a considered judgment that sophisticated investors can protect themselves through negotiation and diligence rather than mandated disclosure.
The judgment rests on an assumption — that the investor will actually do that work. An accredited investor who signs a subscription agreement without reading the governing document has qualified for a regime whose protections depend on behaviour they have not engaged in.
This guide is educational and general; it is not investment or legal advice. Review all offering documents and consult qualified advisers before subscribing.
Frequently Asked Questions
What is a private placement?
An offering of securities that is not registered with the SEC, sold instead under an exemption — most commonly Regulation D. Because it is unregistered, the issuer is not required to provide the disclosure that registration mandates, and the securities are restricted and generally cannot be freely resold.
What documents does an investor receive?
Typically a private placement memorandum describing the offering and its risks, the governing document such as a partnership or operating agreement, and a subscription agreement containing the investor’s representations. The governing document controls the economics and is the one least often read.
Are private placements riskier than public offerings?
They carry different risks. Disclosure is not mandated and varies in quality, the securities are illiquid and restricted, valuation is not market-determined, and there is no regulatory review of the merits. Some private offerings are excellent investments; the point is that the framework provides less protection and shifts more responsibility to the investor.
Does the SEC review a private placement?
No. A Form D is a notice filing, not an application, and no federal or state agency approves the offering or passes on its merits. Language in offering documents saying so is required precisely because investors sometimes assume otherwise.
Can a private placement be sold later?
Generally not freely. Interests sold under an exemption are restricted securities, resale requires registration or another exemption, and the governing documents almost always require consent to any transfer. Secondary markets exist but are thin and typically price at a discount.
Sources
- Securities Act of 1933, Section 4(a)(2) and Regulation D, Rules 501-506
- Securities Act of 1933, Rule 144 (resale of restricted securities)
- SEC Regulation Best Interest, Exchange Act Rule 15l-1
